Arla Foods Ingredients and wheyco, DMK Group's dedicated whey business, will co-exhibit at Fi Europe 2026 in Frankfurt — their first joint trade show appearance since the merger of their respective parent companies. The combined booth, branded under the 'Growing Stronger Together' theme, marks a visible step in consolidating two of Europe's significant whey ingredient portfolios under a unified commercial front.
Whey's Strategic Weight
Whey protein remains one of the most widely used functional ingredients in sports nutrition, clinical nutrition, and fortified food and beverage applications. Its complete amino acid profile, established bioavailability data, and versatile solubility make it a workhorse across finished formulations — from ready-to-mix protein powders and high-protein dairy beverages to pediatric and geriatric medical nutrition products. The consolidation of Arla Foods Ingredients' and wheyco's combined capabilities could translate into broader ingredient breadth, more integrated supply chain options, and stronger co-manufacturing support for formulators operating at scale in Europe and beyond.
Fi Europe, held in Frankfurt, is among the largest ingredient trade platforms in the global food and beverage calendar, drawing procurement, R&D, and innovation teams from across the supply chain. A shared exhibit signals to the market that the post-merger integration between the Arla and DMK parent organizations is advancing beyond corporate structure into customer-facing commercial alignment — a development operators and co-manufacturers will watch closely as they evaluate long-term ingredient sourcing partnerships.
What It Means for Operators
For brands active in sports nutrition and high-protein functional foods, the combined presence raises the prospect of a more unified ingredient offering — potentially simplifying supplier relationships and broadening access to whey fractions, concentrates, and isolates from a single integrated source. European whey ingredient supply has faced periodic tightness tied to raw milk availability and processing capacity, making supplier consolidation a factor with real supply-chain implications for finished-product manufacturers.
The Fi Europe appearance also underscores a broader trend in the functional ingredients and nutraceutical supply chain: upstream consolidation as ingredient companies seek scale to invest in clinical substantiation, regulatory compliance infrastructure, and sustainable sourcing — all increasingly non-negotiable for brand partners selling into health-conscious retail and foodservice channels.
Full details on the joint exhibit's product focus and booth programming had not been released at time of publication.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
Frequently Asked Questions
Why should I care about Arla Foods Ingredients and wheyco exhibiting together at Fi Europe 2026?
This is the first joint booth since DMK Group and Arla merged, signaling that post-merger integration is moving from corporate paperwork into real commercial alignment. If you're sourcing whey protein for sports nutrition or clinical nutrition products at scale, you're now facing a consolidated European whey portfolio with integrated supply chain and co-manufacturing support — that changes your negotiating position and partnership options.
What makes whey protein still relevant in 2026 when plant-based alternatives are everywhere?
Whey delivers a complete amino acid profile with proven bioavailability that plant proteins still can't match on a gram-for-gram basis — it's non-negotiable for pediatric and geriatric medical nutrition, and it remains the default in high-protein dairy and sports nutrition formulations where efficacy matters more than marketing narrative. The data hasn't shifted; the category has simply matured.
Does this merger consolidation give Arla–DMK pricing leverage I should worry about?
Consolidating two major European whey portfolios under one commercial front absolutely increases their negotiating power with buyers — that's the point of the merger. Your window to lock in favorable long-term ingredient sourcing agreements before they extract full margin value from the consolidation is closing, so treat Fi Europe 2026 as a negotiation checkpoint, not a casual networking event.
What formulation categories benefit most from this combined Arla–wheyco capability?
Sports nutrition (ready-to-mix powders), high-protein dairy beverages, and medical nutrition products for pediatric and geriatric populations — anywhere complete amino acid profiles and established bioavailability data are table stakes. If you're working in those categories, the expanded co-manufacturing support and ingredient breadth from the merged portfolio directly reduces your formulation complexity and time-to-market.
How big is Fi Europe 2026 and why does it matter that they're showing up together?
Fi Europe Frankfurt is one of the three largest ingredient trade platforms on the global calendar — it draws procurement, R&D, and innovation teams across the entire supply chain. A unified booth from two merged whey powerhouses signals the market that integration is real and supplier consolidation is accelerating; your sourcing team needs to be there to map the new landscape.